Header Logo

Marc Fisher

Concepts (206)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
43
2020
852
8.660
Why?
Brain Ischemia
31
2019
299
7.160
Why?
Neuroprotective Agents
10
2016
53
2.530
Why?
Tissue Plasminogen Activator
7
2016
108
2.160
Why?
Cerebrovascular Circulation
12
2012
125
2.060
Why?
Clinical Trials as Topic
15
2016
380
2.030
Why?
Infarction, Middle Cerebral Artery
7
2009
57
2.020
Why?
Periodicals as Topic
4
2017
163
1.710
Why?
Thrombectomy
3
2019
103
1.650
Why?
Endovascular Procedures
4
2019
320
1.600
Why?
Diffusion Magnetic Resonance Imaging
10
2009
92
1.440
Why?
Thrombolytic Therapy
7
2016
157
1.240
Why?
Editorial Policies
2
2017
49
1.220
Why?
Reperfusion Injury
4
2016
48
1.090
Why?
Disease Models, Animal
14
2013
1795
1.090
Why?
Platelet Aggregation Inhibitors
4
2009
216
1.070
Why?
Fibrinolytic Agents
4
2010
149
1.050
Why?
Ischemic Attack, Transient
4
2018
76
0.970
Why?
Magnetic Resonance Imaging
7
2009
1333
0.890
Why?
Rats
17
2013
1806
0.870
Why?
Reperfusion
5
2010
25
0.820
Why?
Time Factors
16
2019
3232
0.810
Why?
Treatment Outcome
13
2020
3823
0.790
Why?
Drug Design
3
2010
137
0.760
Why?
Decision Support Techniques
1
2019
154
0.700
Why?
Anticoagulants
5
2020
389
0.700
Why?
Animals
31
2016
17868
0.690
Why?
Magnetic Resonance Angiography
3
2006
121
0.630
Why?
Humans
42
2020
48363
0.630
Why?
Health Planning Guidelines
2
2007
26
0.600
Why?
Warfarin
3
2020
102
0.590
Why?
Rats, Sprague-Dawley
11
2008
506
0.580
Why?
Ticlopidine
2
2006
61
0.560
Why?
Granulocyte Colony-Stimulating Factor
2
2013
34
0.530
Why?
Brain
6
2007
1135
0.500
Why?
Acute Disease
8
2010
624
0.480
Why?
Freezing
1
2011
15
0.470
Why?
Recovery of Function
4
2019
193
0.460
Why?
Embolism
2
2008
31
0.440
Why?
Thrombophilia
1
2010
17
0.440
Why?
Brain Injuries
2
2013
121
0.420
Why?
Aspirin
2
2009
173
0.410
Why?
Male
22
2019
23420
0.400
Why?
Cerebral Infarction
2
2007
53
0.400
Why?
Gadolinium
1
2009
57
0.390
Why?
Intracranial Embolism
1
2009
25
0.390
Why?
Intracellular Signaling Peptides and Proteins
1
2011
309
0.390
Why?
Laser-Doppler Flowmetry
1
2008
4
0.390
Why?
Behavior, Animal
2
2007
175
0.380
Why?
Brain Infarction
1
2008
16
0.380
Why?
Atrial Fibrillation
3
2020
514
0.380
Why?
Hyperoxia
1
2008
11
0.380
Why?
Research
2
2009
187
0.380
Why?
Contrast Media
1
2009
282
0.350
Why?
Biomedical Technology
1
2007
5
0.340
Why?
Cerebral Arteries
1
2007
21
0.340
Why?
Rats, Wistar
4
2013
172
0.330
Why?
Telemedicine
2
2009
207
0.320
Why?
Middle Cerebral Artery
1
2006
34
0.310
Why?
Dimethyl Sulfoxide
1
2005
13
0.310
Why?
Membrane Proteins
1
2011
780
0.300
Why?
Drug Evaluation, Preclinical
1
2005
88
0.290
Why?
Device Approval
1
2005
10
0.290
Why?
Diffusion
5
2008
74
0.280
Why?
Cerebral Cortex
1
2005
206
0.270
Why?
Patient Selection
3
2016
361
0.260
Why?
Recombinant Proteins
3
2016
664
0.260
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2005
185
0.260
Why?
Research Design
2
2005
528
0.260
Why?
Stem Cell Transplantation
1
2003
62
0.260
Why?
Heparin, Low-Molecular-Weight
1
2002
24
0.250
Why?
Factor Xa Inhibitors
2
2020
29
0.240
Why?
Neuroimaging
2
2013
71
0.240
Why?
Heparin
1
2002
107
0.230
Why?
Disease Management
1
2003
179
0.230
Why?
Neurons
2
2011
784
0.230
Why?
Blood Pressure
3
2010
479
0.230
Why?
Aged, 80 and over
5
2020
4230
0.230
Why?
Astrocytes
1
2002
106
0.220
Why?
Drug Therapy, Combination
3
2009
375
0.220
Why?
Risk Factors
4
2019
4225
0.220
Why?
Tomography, X-Ray Computed
1
2006
1055
0.200
Why?
China
1
2019
106
0.200
Why?
Rivaroxaban
1
2018
13
0.190
Why?
Dabigatran
1
2018
18
0.190
Why?
Risk Assessment
2
2019
1593
0.190
Why?
Aged
6
2020
10909
0.180
Why?
Disability Evaluation
1
2019
191
0.180
Why?
Regional Blood Flow
2
2008
93
0.170
Why?
Hemorrhage
3
2019
213
0.170
Why?
Homes for the Aged
1
2019
149
0.170
Why?
Nursing Homes
2
2020
531
0.170
Why?
Neurology
1
2016
22
0.170
Why?
Protein C
1
2016
28
0.170
Why?
Secondary Prevention
3
2018
128
0.170
Why?
Predictive Value of Tests
1
2019
855
0.170
Why?
Registries
1
2019
676
0.160
Why?
Health Services Needs and Demand
1
2017
194
0.150
Why?
Clinical Protocols
1
2016
126
0.150
Why?
Middle Aged
4
2019
13617
0.150
Why?
Retrospective Studies
3
2020
4317
0.150
Why?
Reproducibility of Results
1
2019
1337
0.150
Why?
Randomized Controlled Trials as Topic
2
2009
489
0.140
Why?
Injections, Intravenous
2
2005
147
0.140
Why?
United States
5
2020
6149
0.130
Why?
Cerebral Hemorrhage
2
2005
57
0.130
Why?
Diagnostic Imaging
2
2008
197
0.130
Why?
Practice Patterns, Physicians'
1
2019
690
0.130
Why?
Language
1
2014
113
0.130
Why?
Health Services Accessibility
1
2017
433
0.130
Why?
Tetrazolium Salts
2
2008
14
0.120
Why?
Cognition Disorders
1
2013
203
0.120
Why?
Disks Large Homolog 4 Protein
1
2011
18
0.120
Why?
Medicare
3
2020
434
0.120
Why?
Factor V Deficiency
1
2010
1
0.110
Why?
Antithrombin III Deficiency
1
2010
2
0.110
Why?
Protein S Deficiency
1
2010
2
0.110
Why?
Protein C Deficiency
1
2010
3
0.110
Why?
Vascular Surgical Procedures
1
2013
217
0.110
Why?
Foramen Ovale, Patent
1
2010
11
0.110
Why?
Female
5
2019
26304
0.110
Why?
Cell Death
1
2011
248
0.100
Why?
Cortical Spreading Depression
1
2009
9
0.100
Why?
Cost-Benefit Analysis
1
2010
234
0.100
Why?
Hospital Units
1
2009
8
0.100
Why?
Health Care Sector
1
2009
20
0.100
Why?
Magnetic Field Therapy
1
2008
2
0.100
Why?
Infusions, Intra-Arterial
1
2008
9
0.100
Why?
Image Processing, Computer-Assisted
3
2007
538
0.090
Why?
Administration, Oral
2
2020
298
0.090
Why?
Functional Laterality
2
2006
122
0.090
Why?
Species Specificity
1
2009
322
0.090
Why?
Infusions, Intravenous
1
2008
165
0.090
Why?
Drug Administration Schedule
1
2008
246
0.090
Why?
Guidelines as Topic
1
2009
147
0.090
Why?
Radiography
2
2006
337
0.090
Why?
Case-Control Studies
1
2010
884
0.090
Why?
Peptides
1
2011
501
0.090
Why?
Blood Glucose
1
2010
454
0.090
Why?
Injury Severity Score
1
2007
71
0.090
Why?
Equipment Design
1
2008
274
0.090
Why?
Virginia
1
2007
13
0.090
Why?
Electrocardiography
1
2009
364
0.080
Why?
Practice Guidelines as Topic
1
2010
606
0.080
Why?
Cells, Cultured
1
2011
2042
0.080
Why?
Benzenesulfonates
1
2006
15
0.080
Why?
Brain Mapping
1
2007
189
0.080
Why?
Rats, Inbred WKY
1
2005
11
0.080
Why?
Body Temperature
1
2005
46
0.080
Why?
Drug Industry
1
2005
35
0.080
Why?
Legislation, Drug
1
2005
16
0.070
Why?
Equipment Safety
1
2005
16
0.070
Why?
Product Surveillance, Postmarketing
1
2005
18
0.070
Why?
Carbon Dioxide
1
2005
63
0.070
Why?
Cerebrovascular Disorders
1
2005
61
0.070
Why?
Drug Approval
1
2005
26
0.070
Why?
Models, Animal
1
2005
202
0.070
Why?
United States Food and Drug Administration
1
2005
80
0.070
Why?
Risk
1
2005
388
0.070
Why?
Software
1
2007
325
0.070
Why?
Aspirin, Dipyridamole Drug Combination
1
2003
3
0.070
Why?
Heart Rate
1
2005
266
0.070
Why?
Regression Analysis
1
2005
481
0.070
Why?
Dipyridamole
1
2003
46
0.070
Why?
Oxygen
1
2005
236
0.070
Why?
Hydrogen-Ion Concentration
1
2005
405
0.070
Why?
Recurrence
1
2005
510
0.070
Why?
Drug Combinations
1
2003
120
0.070
Why?
Cohort Studies
2
2020
2076
0.070
Why?
Quality of Health Care
1
2008
485
0.070
Why?
Thrombosis
1
2006
186
0.070
Why?
Pharmaceutical Preparations
1
2005
110
0.070
Why?
Drug Synergism
1
2003
120
0.060
Why?
Odds Ratio
1
2005
785
0.060
Why?
Adult
2
2009
13301
0.060
Why?
Multivariate Analysis
1
2005
877
0.060
Why?
Disease Progression
1
2005
691
0.060
Why?
Treatment Failure
1
2003
171
0.060
Why?
Combined Modality Therapy
1
2003
309
0.060
Why?
Microscopy, Electron
1
2002
248
0.060
Why?
Decision Making
1
2004
322
0.060
Why?
Severity of Illness Index
1
2005
1186
0.050
Why?
Prospective Studies
1
2007
2492
0.050
Why?
Water
1
2002
254
0.050
Why?
Follow-Up Studies
1
2005
1962
0.050
Why?
Drug Substitution
1
2019
34
0.050
Why?
Algorithms
1
2004
886
0.050
Why?
Intracranial Hemorrhages
1
2018
38
0.050
Why?
Thromboembolism
1
2018
57
0.050
Why?
Mice
1
2011
8986
0.050
Why?
Health Care Surveys
1
2019
272
0.050
Why?
Skilled Nursing Facilities
1
2018
76
0.040
Why?
Urbanization
1
2017
2
0.040
Why?
Drug Utilization
1
2019
221
0.040
Why?
Proportional Hazards Models
1
2018
640
0.040
Why?
Nursing Staff, Hospital
1
2017
61
0.040
Why?
Mechanical Thrombolysis
1
2016
29
0.040
Why?
Double-Blind Method
1
2016
561
0.040
Why?
Area Under Curve
1
2013
105
0.030
Why?
Cross-Sectional Studies
1
2019
2046
0.030
Why?
Neuropsychological Tests
1
2013
290
0.030
Why?
Myocardial Infarction
1
2018
864
0.030
Why?
Silicon
1
2006
18
0.020
Why?
Sutures
1
2006
35
0.020
Why?
Perfusion
1
2006
107
0.020
Why?
Surface Properties
1
2006
247
0.020
Why?
Fisher's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (206)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_